Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Qyuns Therapeutics Co., Ltd. Class H ( (HK:2509) ) is now available.
Qyuns Therapeutics Co., Ltd. has successfully completed the conversion of 17,322,400 unlisted shares into H shares, which will be listed on the Hong Kong Stock Exchange starting March 28, 2025. This move marks a significant milestone in the company’s efforts to enhance its market presence and liquidity, potentially impacting its operations and stakeholder interests positively.
More about Qyuns Therapeutics Co., Ltd. Class H
Qyuns Therapeutics Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company focuses on developing and commercializing therapeutic products, with a significant presence in the Hong Kong stock market.
YTD Price Performance: 21.54%
Average Trading Volume: 83,954
Technical Sentiment Signal: Strong Buy
For an in-depth examination of 2509 stock, go to TipRanks’ Stock Analysis page.